Election Day is coming — are you registered to vote?
119th Congress
Independent · Nonpartisan · Reader-supported
HOUSEH.R. 3029· 119th Congress

U.S. Sets Safety Standards for Custom DNA Synthesis

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Sponsor
Andrea Salinas (D-OR)
Introduced
Apr 28, 2025
Last Action
Jul 21, 2026
Passage
68%
Introduced
Apr 28, 2025
Committee
Floor Vote
Jul 21, 2026
4
Both Chambers
5
Enacted
01 — The Text

What.

  • NIST must develop technical standards and best practices for screening custom DNA/RNA synthesis to prevent misuse by bad actors.
  • Requires NIST to convene biotech companies, researchers, and security experts to establish consensus screening requirements and update them regularly.
  • NIST must submit findings to Congress on screening mechanisms, operational security, and risk management for synthetic biology and AI-assisted biotech.
02 — The Stakes

So what?

  • Biotech and synthetic biology companies face new compliance expectations around screening who orders custom genetic material and why.
  • U.S. gains guardrails against intentional or accidental creation of dangerous biological agents as DNA synthesis becomes cheaper and easier.
  • Security researchers and public health officials get a formal process to shape industry standards rather than leaving screening to individual companies.
03 — The Path

Now what?

  • House passed it July 20; now in Senate Commerce Committee. Needs Senate vote and presidential signature to become law.
  • Biotech companies and research institutions should monitor NIST guidance once it's released—likely to become baseline compliance expectations.
  • Concerned citizens can track Senate progress or contact senators on Commerce Committee if they care about biosecurity policy.
Legislative History

Actions.

  • Jul 21, 2026Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
  • Jul 20, 2026Motion to reconsider laid on the table Agreed to without objection.
  • Jul 20, 2026On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
  • Jul 20, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
  • Jul 20, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.
  • Jul 20, 2026Considered under suspension of the rules. (consideration: CR H4666-4667)
  • Jul 20, 2026Mr. Babin moved to suspend the rules and pass the bill, as amended.
  • Jul 16, 2026Placed on the Union Calendar, Calendar No. 654.